|
Market Closed -
OTC Markets
15:06:37 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| 12-28 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 25-10-21 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Business description: Seelos Therapeutics, Inc.

Number of employees: 8
Sales by Activity: Seelos Therapeutics, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) |
|---|---|---|---|---|---|
Pharmaceuticals | 375K | - | - | - | 2.2M |
Geographical breakdown of sales: Seelos Therapeutics, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) |
|---|---|---|---|---|---|
United States | 375K | - | - | - | 2.2M |
Executive Committee: Seelos Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 66 | 2018-12-31 |
Anthony Marciano
IRC | Investor Relations Contact | - | 2018-12-31 |
Company details: Seelos Therapeutics, Inc.

Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 1 | ||
| -1.34% | -3.09% | +56.10% | +68.83% | 65.45B | ||
| -0.86% | -3.86% | +6.90% | +89.13% | 58.93B | ||
| +0.63% | +0.75% | +26.70% | +87.85% | 55.21B | ||
| -2.34% | -3.90% | +10.90% | +115.97% | 46.1B | ||
| +0.09% | -6.08% | +18.67% | +25.90% | 42.49B | ||
| -2.58% | +0.24% | +18.54% | +41.28% | 35.56B | ||
| -1.76% | -11.56% | +126.44% | +649.27% | 34.57B | ||
| +0.17% | -0.54% | +77.41% | +58.15% | 32.46B | ||
| -1.69% | -0.79% | -40.58% | +382.68% | 26.28B | ||
| Average | -0.96% | -3.06% | +33.45% | +168.78% | 40B | |
| Weighted average by Cap. | -1.00% | -3.29% | +33.56% | +143.33% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SEELQ Stock
- Company Seelos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















